Form D · Other Health Care
Altrazeal Life Sciences Inc.
Addison, TX · CIK 0001168220
Offering snapshot reported Sep 18, 2023 · SEC filing
- Reported sold
- $2.22M Offering amount: $6.6M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $250K Reported outside-investor minimum
- First sale
- Jun 30, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 18, 2023 | Initial | $2,216,621 | No comparison | 2 | SEC filing |
| Nov 25, 2019 | Initial | $690,000 | No comparison | 4 | SEC filing |
| Apr 12, 2017 | Initial | $5,500,000 | No comparison | 2 | SEC filing |
| Apr 13, 2016 | Initial | $1,714,000 | No comparison | 15 | SEC filing |
| Sep 11, 2015 | Initial | $1,550,225 | No comparison | 5 | SEC filing |
| Apr 20, 2015 | Initial | $500,000 | No comparison | 1 | SEC filing |
| Mar 14, 2014 | Initial | $42,600 | No comparison | 1 | SEC filing |
| Jul 8, 2013 | Initial | $87,000 | No comparison | 1 | SEC filing |
| Apr 15, 2013 | Initial | $58,250 | No comparison | 4 | SEC filing |
| Jan 10, 2013 | Initial | $400,000 | No comparison | 1 | SEC filing |
| Jul 10, 2012 | Initial | $2,210,000 | No comparison | 1 | SEC filing |
| Sep 26, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Nov 14, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-492325
Source: Form D, filed Sep 18, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Arindam Bose | Director |
| Jeffrey B. Davis | Director |
| Robert F. Goldrich | Director |
| Kerry P. Gray | Director, Executive |
| Helmut Kerschbaumer | Director, Executive |
| Klaus Kuehne | Director |
| Robert Mandell | Director |
| Pk Ramachandran | Executive |
| Bradley Sacks | Director |
| Dane Shackleford | Executive |
| Vaidehi Shah | Director, Executive |
| Anish Shah | Director, Executive |
| Jeffrey A. Stone | Director |
| Oksana Tiedt | Director, Executive |
| Terrance K. Wallberg | Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
4410 Beltway Drive
Addison, TX, 75001
Addison, TX, 75001